RMD ResMed Inc.
$233.38▲ +4.66%
Healthcare
Other
Volume 436.6K
Avg Volume (10D) 1.22M
Key Metrics & Fundamentals
Market Cap
$33.67B
P/E Ratio
22.4
Div Yield
1.18%
52W Range
180.27 - 284.87
% vs 50 MA
2.65%
% vs 200 MA
-2.08%
RSI-14
48.6
MACD Histogram
-2.4500
Beta (1Y vs SPY)
0.44
Free Cash Flow
$397.38M
Gross Rev
$1.46B
Gross Profit
$861.22M
EBITDA
$503.83M
COGS
$602.43M
Operating Exp
$412.51M
Operating Income
$448.71M
EBIT
$448.71M
Pretax Income
$474.16M
Net Income
$383.43M
EPS (Diluted)
2.64
Price & Volume History
Loading chart…
Recent News
ResMed Projected to Attain High-Single-Digit EPS Growth in Next Three Years, RBC Says
MT Newswires · Sep 15, 2026 3:00 PM

Is This the Right Time to Retain Resmed Stock in Your Portfolio?
Zacks · Sep 15, 2026 2:10 PM

Ulta Beauty, Etsy upgraded: Wall Street's top analyst calls
The Fly · Sep 15, 2026 1:35 PM

Here Are Tuesday’s Top Wall Street Analyst Research Calls: Autodesk, Eli Lilly, Etsy, Lear, Netskope, Nokia, Northrop Grumman, Rapid7, Rivian Automotive, Ulta Beauty, and More
24/7 Wall St. · Sep 15, 2026 12:04 PM
RBC Upgrades ResMed to Outperform From Sector Perform, Raises Price Target to $262 From $244
MT Newswires · Sep 15, 2026 10:20 AM

Patient Monitoring Stocks Q2 Teardown: ResMed (NYSE:RMD) Vs The Rest
StockStory · Sep 14, 2026 7:15 PM

ResMed Stock: Is RMD Underperforming the Healthcare Sector?
Barchart · Sep 14, 2026 1:07 PM
Resmed Insider Sold Shares Worth $1,110,191, According to a Recent SEC Filing
MT Newswires · Sep 10, 2026 11:00 AM
Citigroup Adjusts Price Target on ResMed to $240 From $235, Keeps Neutral Rating
MT Newswires · Sep 10, 2026 10:15 AM
Morgan Stanley Adjusts Price Target on ResMed to $225 From $227, Keeps Equalweight Rating
MT Newswires · Sep 3, 2026 10:06 AM
Financial Overview - Income Statement
Quarterly
Jun 2026
See RMD's money flow as a full page
Social Sentiment
Avg +0.56 · 10 posts
DiscussionDoes taking RMDs negate NUA?
r/investing · Jul 28, 2026
The discussion centers around optimizing retirement withdrawals for potential investment benefits.
positive
+0.60
DiscussionMy Portfolio vs S&P 500 (Last 3 Weeks)
r/stocks · Jul 10, 2026
The author highlights ResMed's performance within their portfolio.
positive
+0.60
My buys for Monday 3/16/26
r/stocks · Mar 15, 2026
RMD is highlighted as a positive investment based on the poster's criteria.
positive
+0.60
DiscussionSpend down inheritance or spend 401k money first to minimize taxes and maximize legacy?
r/investing · Feb 18, 2026
The post directly addresses strategies for RMDs using Roth conversions, a central theme.
positive
+0.70
DiscussionShould beginners consider Roth conversions early on?
r/investing · Nov 21, 2025
Discussed as a tool for retirement planning.
positive
+0.30
Page 1 of 2 (10 total)
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.